Ethical and regulatory issues of pragmatic cluster randomized trials in contemporary health systems

Clinical Trials

Volumn 12, Issue 3, 2015, Pages 276-286

  Anderson, Monique L ^a,b   Califf, Robert M ^a,b   Sugarman, Jeremy ^c,d  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

clinical trials; cluster randomized trials; Ethics; pragmatic clinical trials; regulations

Indexed keywords

ARTICLE; CLINICAL RESEARCH; HEALTH CARE SYSTEM; HUMAN; INFORMED CONSENT; MEDICAL ETHICS; PRIORITY JOURNAL; PRIVACY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STUDY DESIGN; CONFIDENTIALITY; ETHICS; LEGISLATION AND JURISPRUDENCE; METHODOLOGY; NATIONAL HEALTH ORGANIZATION; PROCEDURES; PROFESSIONAL STANDARD; UNITED STATES;

CONFIDENTIALITY; ETHICS COMMITTEES, RESEARCH; INFORMED CONSENT; NATIONAL INSTITUTES OF HEALTH (U.S.); RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; UNITED STATES;

EID: 84929164648     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774515571140     Document Type: Article

References (44)

1. Murray DM Design and analysis of group-randomized trials. New York: Oxford University Press ; 1998 :
2. Donner A, Klar N Design and analysis of cluster randomization trials in health research. London: Arnold ; 2000 :
3. Hayes RJ, Moulton LH Cluster randomised trials. Boca Raton, FL: Taylor & Francis Group, LLC ; 2009 :
4. Rothman KJ, Greenland S Modern epidemiology. 2 nd ed. Philadelphia, PA: Lippincott Williams & Wilkins, 1998, pp. 71-73. Rothman KJ Greenland S, ed. Philadelphia, PA: Lippincott Williams & Wilkins ; 1998: 71-73.
5. U.S. Department of Health and Human Services website. Recommendations on regulatory issues in cluster randomized trials, http://www.hhs.gov/ohrp/sachrp/mtgings/mtg03-14/clusterstudiesrecommendations.html (accessed 5 December 2014).
6. Selby JV, Beal AC, Frank L. The Patient-Centered Outcomes Research Institute (PCORI): national priorities for research and initial research agenda. JAMA. 2012 ; 307: 1583-1584
7. Matthews S. New NIH effort seeks to find ways to make trials run smoother. Nat Med. 2012 ; 18: 1598
8. Institute of Medicine. Initial national priorities for comparative effectiveness research. Washington, DC: National Academies Press, 2009, http://books.nap.edu/openbook.php?record-id=12648&page=R4 (accessed 3 February 2014).
9. Institute of Medicine. Best care at lower cost: the path to continuously learning health care in America. Washington, DC: National Academies Press, 2012, http://books.nap.edu/openbook.php?record-id=13444 (accessed 3 February 2014).
10. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003 ; 290: 1624-1632
11. Mazor KM, Sabin JE, Boudreau D, et al. Cluster randomized trials: opportunities and barriers identified by leaders of eight health plans. Med Care. 2007 ; 45: S29 - S37
12. Edwards SJ, Braunholtz DA, Lilford RJ, et al. Ethical issues in the design and conduct of cluster randomised controlled trials. BMJ. 1999 ; 318: 1407-1409
13. Donner A, Klar N. Pitfalls of and controversies in cluster randomization trials. Am J Public Health. 2004 ; 94: 416-422
14. Eldridge SM, Ashby D, Feder GS. Informed patient consent to participation in cluster randomized trials: an empirical exploration of trials in primary care. Clin Trials. 2005 ; 2: 91-98
15. Sim J, Dawson A. Informed consent and cluster-randomized trials. Am J Public Health. 2012 ; 102: 480-485
16. Giraudeau B, Caille A, Le Gouge A, et al. Participant informed consent in cluster randomized trials: review. PLoS One. 2012 ; 7: e40436
17. Weijer C, Grimshaw JM, Eccles MP, et al. The Ottawa Statement on the ethical design and conduct of cluster randomized trials. PLoS Med. 2012 ; 9: e1001346
18. Macklin R. Cluster randomized trials: another look. Hastings Cent Rep. 2014 ; 44: 37-43
19. Sugarman J, Califf RM. Ethics and regulatory complexities for pragmatic clinical trials. JAMA. 2014 ; 311: 2381-2382
20. Mann H, Reyes M. Identifying the human research subject in cluster randomized controlled trials. IRB. 2008 ; 30: 14-18
21. McRae AD, Weijer C, Binik A, et al. Who is the research subject in cluster randomized trials in health research?. Trials. 2011 ; 12: 183
22. NIH Health Care Systems Research Collaboratory website. Demonstration Projects. UH3 Projects: Active Bathing to Eliminate Infection (ABATE), https://www.nihcollaboratory.org/demonstration-projects/Pages/ABATE.aspx (accessed 3 February 2015).
23. U.S. Department of Health and Human Services website. Code of Federal Regulations. 45 CFR 46.102(f). Definitions - Human Subject, http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html#46.102 (accessed 30 January 2014)
24. Merriam-Webster Online Dictionary. Definition of "Gatekeeper,"http://www.merriam-webster.com/dictionary/gatekeeper (accessed 1 June 2014).
25. NIH Health Care Systems Research Collaboratory website. UH3 project: time to reduce mortality in end-stage renal disease (TIME), https://www.nihcollaboratory.org/demonstration-projects/Pages/TiME.aspx (accessed 17 December 2014).
26. Gallo A, Weijer C, White A, et al. What is the role and authority of gatekeepers in cluster randomized trials in health research?. Trials. 2012 ; 13: 116
27. Sabin JE, Mazor K, Meterko V, et al. Comparing drug effectiveness at health plans: the ethics of cluster randomized trials. Hastings Cent Rep. 2008 ; 38: 39-48
28. Largent EA, Joffe S, Miller FG. Can research and care be ethically integrated?. Hastings Cent Rep. 2011 ; 41: 37-46
29. NIH Health Care Systems Research Collaboratory website. Demonstration project ethics and regulatory documentation, https://www.nihcollaboratory.org/Pages/sachrp.aspx (accessed 3 February 2015).
30. McRae AD, Weijer C, Binik A, et al. When is informed consent required in cluster randomized trials in health research?. Trials. 2011 ; 12: 202
31. U.S. Department of Health and Human Services website. Code of Federal Regulations. 45 CFR 46.102(i). Definitions - Minimal Risk, http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html#46.102 (accessed 30 January 2014).
32. Wendler D, Belsky L, Thompson KM, et al. Quantifying the federal minimal risk standard: implications for pediatric research without a prospect of direct benefit. JAMA. 2005 ; 294: 826-832
33. Westra AE, Wit JM, Sukhai RN, et al. How best to define the concept of minimal risk. J Pediatr. 2011 ; 159: 496-500
34. Petersen LA, Simpson K, Sorelle R, et al. How variability in the institutional review board review process affects minimal-risk multisite health services research. Ann Intern Med. 2012 ; 156: 728-735
35. U.S. Department of Health and Human Services. Office for Human Research Protections. Draft guidance on disclosing reasonably foreseeable risks in research evaluating standards of care, http://www.hhs.gov/ohrp/newsroom/rfc/comstdofcare.html (accessed 5 December 2014).
36. N Engl J Med. 2014 ; 371: 2125-2126
37. U.S. Department of Health and Human Services website. Code of Federal Regulations. 45 CFR 46.111. Criteria for IRB Approval of Research, http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html (accessed 17 December 2014).
38. U.S. Food and Drug Administration website. Code of Federal Regulations. 21 CFR 50.24. Exception from informed consent requirements for emergency research, http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=50.24 (accessed 31 January 2014).
39. U.S. Food and Drug Administration website. Code of Federal Regulations. 21 CFR 56.109.c1. Institutional Review Boards. Subpart C - IRB functions and operations, http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=56.109 (accessed 29 December 2013).
40. Department of Health and Human Services webpage. Health information privacy. The Privacy Rule, http://www.hhs.gov/ocr/privacy/hipaa/administrative/privacyrule/ (accessed 26 November 2013).
41. Department of Health and Human Services webpage. Health information privacy. Research, http://www.hhs.gov/ocr/privacy/hipaa/understanding/special/research/ (accessed 26 November 2013).
42. Littenberg B, MacLean CD. Passive consent for clinical research in the age of HIPAA. J Gen Intern Med. 2006 ; 21: 207-211
43. PetersonED. Research methods to speed the development of better evidence - the registries example. In: Evidence-based medicine and the changing nature of healthcare: 2007 IOM annual meeting summary, Institute of Medicine, 2007. Washington, DC: National Academies Press, http://www.ncbi.nlm.nih.gov/books/NBK52826/ (accessed 30 December 2013).
44. NIH Health Care Systems Research Collaboratory website. UH3 project: pragmatic trial of population-based programs to prevent suicide attempt, https://www.nihcollaboratory.org/demonstration-projects/Pages/Suicide%20Prevention.aspx (accessed 17 December 2014).